Assessing the Minimal Important Difference (MID) of the Treatment Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD)

NCT02005198 · clinicaltrials.gov ↗

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Hormone Disorder
Adult Growth Hormone Deficiency

Interventions

OTHER: No treatment given

Sponsor

Novo Nordisk A/S